NSCLC: from tumorigenesis, immune checkpoint misuse to current and future targeted therapy.

Raskova Kafkova L, Mierzwicka JM, Chakraborty P, Jakubec P, Fischer O, Skarda J, Maly P, Raska M.

Open source

DOI: 10.3389/fimmu.2024.1342086
Published: 2024-02-07
Container: Front Immunol
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2024.1342086,
  title = {NSCLC: from tumorigenesis, immune checkpoint misuse to current and future targeted therapy.},
  author = {Raskova Kafkova L and  Mierzwicka JM and  Chakraborty P and  Jakubec P and  Fischer O and  Skarda J and  Maly P and  Raska M.},
  year = {2024},
  journal = {Front Immunol},
  doi = {10.3389/fimmu.2024.1342086},
  url = {https://doi.org/10.3389/fimmu.2024.1342086}
}

RIS

TY  - JOUR
TI  - NSCLC: from tumorigenesis, immune checkpoint misuse to current and future targeted therapy.
AU  - Raskova Kafkova L
AU  -  Mierzwicka JM
AU  -  Chakraborty P
AU  -  Jakubec P
AU  -  Fischer O
AU  -  Skarda J
AU  -  Maly P
AU  -  Raska M.
PY  - 2024
JO  - Front Immunol
DO  - 10.3389/fimmu.2024.1342086
UR  - https://doi.org/10.3389/fimmu.2024.1342086
ER  -

APA

L, R. K., JM, M., P, C., P, J., O, F., J, S., P, M., & M., R. (2024). NSCLC: from tumorigenesis, immune checkpoint misuse to current and future targeted therapy.. Front Immunol. https://doi.org/10.3389/fimmu.2024.1342086

Source records

europe-pmc · retrieved 2026-09-27T00:20:03.762Z
doaj · retrieved 2026-09-27T00:20:03.774Z